Abstract: There is disclosed a combinatory separation system comprising: a first compartment adapted to handle a mixture with magnetic beads having an affinity for molecules, comprising a magnet to attract the beads, a second compartment adapted to receive said magnetic beads transferred thereto with a flow of liquid, and said at least one second compartment is adapted to elute said at least one type of molecules to be separated from said magnetic beads, said at least one second compartment has an outlet comprising means for retaining said magnetic beads in the at least one second compartment. Advantages include that the process becomes simpler quicker and thereby less expensive, since the method is able to remove cells and particles, separate molecules and perform virus inactivation in fewer steps compared to the prior art. Further the method is able to provide a more concentrated end product.

Abstract: The invention relates to a composition comprising a GLP-1/GLP-2 dual agonist for use in the treatment of a patient receiving parenteral nutrition.

Abstract: The present invention relates to an agonist combination comprising a GLP-1 agonist and a GLP-2 agonist, for use in the treatment of a patient who has undergone surgical resection of the bowel.

Abstract: There is disclosed a combinatory separation system comprising: a first compartment adapted to handle a mixture with magnetic beads having an affinity for molecules, comprising a magnet to attract the beads, a second compartment adapted to receive said magnetic beads transferred thereto with a flow of liquid, and said at least one second compartment is adapted to elute said at least one type of molecules to be separated from said magnetic beads, said at least one second compartment has an outlet comprising means for retaining said magnetic beads in the at least one second compartment. Advantages include that the process becomes simpler quicker and thereby less expensive, since the method is able to remove cells and particles, separate molecules and perform virus inactivation in fewer steps compared to the prior art. Further the method is able to provide a more concentrated end product.

Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.

Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.

Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.

Abstract: A locking mechanism for a collapsible ladder (1) comprising several ladder sections (5), each ladder section comprising two ladder bars (2, 3) arranged parallel to each other and interconnected at one end by a rung to form a U-shaped ladder section, and where each ladder section (5) is telescopically inserted into a lower ladder section to form a collapsible ladder (1), and where dampers (23) are provided at the lower end of the ladder bars (2, 3, and where the locking mechanism comprises retaining mechanisms (20, 41) provided on each ladder bar (2, 3), where a single pair of actuators of the locking mechanism can be arranged on any of the ladder sections (5) and still be able to collapse the entire ladder (1).

Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.

Abstract: This invention relates to novel methods of promoting the healing or closure of perforated tympanic membranes or wounds, as well as methods for minimizing scar formation and removing necrotic tissue. In particular the invention relates to the use of components of the plasminogen activating system, especially mini-plasminogen, mini-plasmin, micro-plasminogen, micro-plasmin, delta-plasminogen, and delta-plasmintopromote wound healing processes.

Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.

Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.

Abstract: A collapsible working platform including a working platform and a first and a second telescopically collapsible ladder leg, where the first and second legs are hingedly connected to one end of the working platform, each to a separate end of the working platform. Each of the first and second legs includes several ladder sections. Each ladder section is telescopically inserted into a lower ladder section to form a collapsible ladder including at least two ladder sections. The working platform includes two platform parts. The platform parts are hingedly connected to each other at one end and connected to a respective ladder leg at the other end. The two platform parts are foldable so that the platform parts are arranged in parallel when placed in a folded position.

Abstract: A collapsible stepladder including a first and a second ladder leg, where the legs are hingedly connected to each other in one end, and each of the ladder legs includes several ladder sections. Each section includes two ladder bars arranged parallelly to each other and interconnected at one end by a rung to form a U-shaped ladder section. Furthermore, each ladder section is telescopically inserted into a lower ladder section to form a collapsible ladder including at least three ladder sections, where the stepladder is provided with release mechanisms on each of the ladder legs that can be operated from the same side of the stepladder.

Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.

Abstract: A locking mechanism for a collapsible ladder (1) comprising several ladder sections (5), each ladder section comprising two ladder bars (2, 3) arranged parallel to each other and interconnected at one end by a rung to form a U-shaped ladder section, and where each ladder section (5) is telescopically inserted into a lower ladder section to form a collapsible ladder (1), and where dampers (23) are provided at the lower end of the ladder bars (2, 3, and where the locking mechanism comprises retaining mechanisms (20, 41) provided on each ladder bar (2, 3), where a single pair of actuators of the locking mechanism can be arranged on any of the ladder sections (5) and still be able to collapse the entire ladder (1).

Abstract: A collapsible stepladder (1) comprising two ladder legs (2, 3), where the legs (2, 3) are hingedly connected to each other in one end. Each of the ladder legs (2, 3) comprises several ladder sections (4a-4d), and where each section comprises two ladder bars (6, 7) arranged parallel to each other and interconnected at one end by a rung (8) to form a U-shaped ladder section. The ladder sections are telescopically inserted into a lower ladder section (4e) to form a collapsible ladder comprising at least three ladder sections. One of the ladder legs (3) is provided with a support part (12) in one end. The support part (12) is telescopically extendible from the ladder leg (3) and forms an extension ladder of the ladder leg and where the support part (12) projects above a hinge (5) between the two ladder legs (2, 3).

Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.